SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 25.45-0.4%Dec 23 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Turbo Lawyer who wrote (3930)9/27/1997 1:20:00 AM
From: Andrew H   of 17367
 
Turbo, you are most worthy. I don't really know if any analysts provide coverage from Xoma, but I'm sure Robert and George would know. Word has it that Xoma is in discussions with some large pharms for a deal involving the P3s for BPI for hem trauma. IMO, coverage would be a distinct possibility after this deal is announced.

If not then, then after the P3 results from the meningo trials are reported. Certainly such coverage would give a nice boost to the stock price.

Sure would be nice to have bought IMNX at 16 before the DLJ rec!!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext